1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for
Study
1.2.3. Key Market
Segmentations
2.
Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3.
Executive Summary
3.1. Overview of the
Market
3.2. Overview of Key
Market Segmentations
3.3. Overview of Key
Market Players
3.4. Overview of Key
Regions/Countries
3.5. Overview of Market
Drivers, Challenges, Trends
4.
Voice of Customer
5. Global Autoinjectors
Market Outlook
5.1.
Market Size & Forecast
5.1.1. By Value
5.2.
Market Share & Forecast
5.2.1. By Therapy (Rheumatoid Arthritis, Multiple Sclerosis, Diabetes,
Anaphylaxis, Others)
5.2.2. By Design (Standardized v/s Customized)
5.2.3. By Product (Prefilled v/s Fillable)
5.2.4. By Technology (Automated v/s Manual)
5.2.5. By Type (Disposable v/s Reusable)
5.2.6. By Route of Administration (Intravenous v/s Subcutaneous)
5.2.7. By End User (Hospitals & Clinics, Ambulatory Care Settings, Home
Care Settings)
5.2.8. By Company (2022)
5.2.9. By Region
5.3.
Product Market Map
6. North America
Autoinjectors Market Outlook
6.1.
Market Size & Forecast
6.1.1. By Value
6.2.
Market Share & Forecast
6.2.1. By Therapy
6.2.2. By Design
6.2.3. By Product
6.2.4. By Technology
6.2.5. By Type
6.2.6. By Route of Administration
6.2.7. By End User
6.2.8. By Country
6.3.
North America: Country Analysis
6.3.1. United States
Autoinjectors Market Outlook
6.3.1.1.
Market Size & Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share & Forecast
6.3.1.2.1.
By Therapy
6.3.1.2.2.
By Design
6.3.1.2.3.
By Product
6.3.1.2.4.
By Technology
6.3.1.2.5.
By Type
6.3.1.2.6.
By Route of Administration
6.3.1.2.7.
By End User
6.3.2. Mexico Autoinjectors
Market Outlook
6.3.2.1.
Market Size & Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share & Forecast
6.3.2.2.1.
By Therapy
6.3.2.2.2.
By Design
6.3.2.2.3.
By Product
6.3.2.2.4.
By Technology
6.3.2.2.5.
By Type
6.3.2.2.6.
By Route of Administration
6.3.2.2.7.
By End User
6.3.3. Canada Autoinjectors
Market Outlook
6.3.3.1.
Market Size & Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share & Forecast
6.3.3.2.1.
By Therapy
6.3.3.2.2.
By Design
6.3.3.2.3.
By Product
6.3.3.2.4.
By Technology
6.3.3.2.5.
By Type
6.3.3.2.6.
By Route of Administration
6.3.3.2.7.
By End User
7. Europe Autoinjectors
Market Outlook
7.1.
Market Size & Forecast
7.1.1. By Value
7.2.
Market Share & Forecast
7.2.1. By Therapy
7.2.2. By Design
7.2.3. By Product
7.2.4. By Technology
7.2.5. By Type
7.2.6. By Route of Administration
7.2.7. By End User
7.2.8. By Country
7.3.
Europe: Country Analysis
7.3.1. France Autoinjectors
Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Therapy
7.3.1.2.2.
By Design
7.3.1.2.3.
By Product
7.3.1.2.4.
By Technology
7.3.1.2.5.
By Type
7.3.1.2.6.
By Route of Administration
7.3.1.2.7.
By End User
7.3.2. Germany
Autoinjectors Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Therapy
7.3.2.2.2.
By Design
7.3.2.2.3.
By Product
7.3.2.2.4.
By Technology
7.3.2.2.5.
By Type
7.3.2.2.6.
By Route of Administration
7.3.2.2.7.
By End User
7.3.3. United Kingdom
Autoinjectors Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Therapy
7.3.3.2.2.
By Design
7.3.3.2.3.
By Product
7.3.3.2.4.
By Technology
7.3.3.2.5.
By Type
7.3.3.2.6.
By Route of Administration
7.3.3.2.7.
By End User
7.3.4. Italy Autoinjectors
Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By Therapy
7.3.4.2.2.
By Design
7.3.4.2.3.
By Product
7.3.4.2.4.
By Technology
7.3.4.2.5.
By Type
7.3.4.2.6.
By Route of Administration
7.3.4.2.7.
By End User
7.3.5. Spain Autoinjectors
Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By Therapy
7.3.5.2.2.
By Design
7.3.5.2.3.
By Product
7.3.5.2.4.
By Technology
7.3.5.2.5.
By Type
7.3.5.2.6.
By Route of Administration
7.3.5.2.7.
By End User
8. Asia-Pacific
Autoinjectors Market Outlook
8.1.
Market Size & Forecast
8.1.1. By Value
8.2.
Market Share & Forecast
8.2.1. By Therapy
8.2.2. By Design
8.2.3. By Product
8.2.4. By Technology
8.2.5. By Type
8.2.6. By Route of Administration
8.2.7. By End User
8.2.8. By Country
8.3.
Asia-Pacific: Country Analysis
8.3.1. China Autoinjectors
Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Therapy
8.3.1.2.2.
By Design
8.3.1.2.3.
By Product
8.3.1.2.4.
By Technology
8.3.1.2.5.
By Type
8.3.1.2.6.
By Route of Administration
8.3.1.2.7.
By End User
8.3.2. India Autoinjectors Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Therapy
8.3.2.2.2.
By Design
8.3.2.2.3.
By Product
8.3.2.2.4.
By Technology
8.3.2.2.5.
By Type
8.3.2.2.6.
By Route of Administration
8.3.2.2.7.
By End User
8.3.3. South Korea
Autoinjectors Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Therapy
8.3.3.2.2.
By Design
8.3.3.2.3.
By Product
8.3.3.2.4.
By Technology
8.3.3.2.5.
By Type
8.3.3.2.6.
By Route of Administration
8.3.3.2.7.
By End User
8.3.4. Japan Autoinjectors
Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Therapy
8.3.4.2.2.
By Design
8.3.4.2.3.
By Product
8.3.4.2.4.
By Technology
8.3.4.2.5.
By Type
8.3.4.2.6.
By Route of Administration
8.3.4.2.7.
By End User
8.3.5. Australia
Autoinjectors Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Therapy
8.3.5.2.2.
By Design
8.3.5.2.3.
By Product
8.3.5.2.4.
By Technology
8.3.5.2.5.
By Type
8.3.5.2.6.
By Route of Administration
8.3.5.2.7.
By End User
9. South America Autoinjectors
Market Outlook
9.1.
Market Size & Forecast
9.1.1. By Value
9.2.
Market Share & Forecast
9.2.1. By Therapy
9.2.2. By Design
9.2.3. By Product
9.2.4. By Technology
9.2.5. By Type
9.2.6. By Route of Administration
9.2.7. By End User
9.2.8. By Country
9.3.
South America: Country Analysis
9.3.1. Brazil Autoinjectors
Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Therapy
9.3.1.2.2.
By Design
9.3.1.2.3.
By Product
9.3.1.2.4.
By Technology
9.3.1.2.5.
By Type
9.3.1.2.6.
By Route of Administration
9.3.1.2.7.
By End User
9.3.2. Argentina
Autoinjectors Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Therapy
9.3.2.2.2.
By Design
9.3.2.2.3.
By Product
9.3.2.2.4.
By Technology
9.3.2.2.5.
By Type
9.3.2.2.6.
By Route of Administration
9.3.2.2.7.
By End User
9.3.3. Colombia
Autoinjectors Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Therapy
9.3.3.2.2.
By Design
9.3.3.2.3.
By Product
9.3.3.2.4.
By Technology
9.3.3.2.5.
By Type
9.3.3.2.6.
By Route of Administration
9.3.3.2.7.
By End User
10. Middle East and
Africa Autoinjectors Market Outlook
10.1.
Market Size & Forecast
10.1.1. By Value
10.2.
Market Share & Forecast
10.2.1. By Therapy
10.2.2. By Design
10.2.3. By Product
10.2.4. By Technology
10.2.5. By Type
10.2.6. By Route of Administration
10.2.7. By End User
10.2.8. By Country
10.3.
MEA: Country Analysis
10.3.1. South Africa
Autoinjectors Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1.
By Therapy
10.3.1.2.2.
By Design
10.3.1.2.3.
By Product
10.3.1.2.4.
By Technology
10.3.1.2.5.
By Type
10.3.1.2.6.
By Route of Administration
10.3.1.2.7.
By End User
10.3.2. Saudi Arabia
Autoinjectors Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1.
By Therapy
10.3.2.2.2.
By Design
10.3.2.2.3.
By Product
10.3.2.2.4.
By Technology
10.3.2.2.5.
By Type
10.3.2.2.6.
By Route of Administration
10.3.2.2.7.
By End User
10.3.3. UAE Autoinjectors
Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1.
By Therapy
10.3.3.2.2.
By Design
10.3.3.2.3.
By Product
10.3.3.2.4.
By Technology
10.3.3.2.5.
By Type
10.3.3.2.6.
By Route of Administration
10.3.3.2.7.
By End User
10.3.4. Kuwait Autoinjectors
Market Outlook
10.3.4.1. Market Size & Forecast
10.3.4.1.1.
By Value
10.3.4.2. Market Share & Forecast
10.3.4.2.1.
By Therapy
10.3.4.2.2.
By Design
10.3.4.2.3.
By Product
10.3.4.2.4.
By Technology
10.3.4.2.5.
By Type
10.3.4.2.6.
By Route of Administration
10.3.4.2.7.
By End User
11. Market Dynamics
11.1.
Drivers
11.2.
Challenges
12. Market Trends &
Developments
13. Competitive
Landscape
13.1.
Mylan N.V.
13.2.
AbbVie Inc.
13.3.
Eli Lilly and Company
13.4.
Ypsomed Holding AG
13.5.
Amgen Inc.
13.6.
Becton, Dickinson, and Company
13.7.
GlaxoSmithKline plc
13.8.
Johnson & Johnson International, Inc.
13.9.
Teva Pharmaceutical Industries Ltd
13.10.
Antares Pharma, Inc.
13.11.
Merck KGaA
13.12.
F. Hoffmann-LA Roche
13.13.
Bayer AG
13.14.
Bristol-Myers Squibb Company
13.15.
Medeca Pharma AB
Strategic Recommendations